C14orf108 Inhibitors
C14orf108 inhibitors refer to a class of chemical compounds specifically designed to inhibit the function of the protein encoded by the C14orf108 gene, which is located on chromosome 14 and is initially characterized as an open reading frame (orf). The designation "orf" suggests that the protein's functions are not well-defined within the realm of biological research and may require further investigation for complete understanding. Inhibitors targeting C14orf108 would be synthesized to bind to this protein and alter its activity, with the aim of understanding its role within the cellular context. These inhibitory compounds are usually the result of extensive research into the protein's structure and function and are valuable tools in elucidating the biological pathways in which the protein participates.
The development of C14orf108 inhibitors would begin with a thorough investigation into the protein's structure, post-translational modifications, and interactions with other cellular components. Researchers might employ advanced techniques such as X-ray crystallography, cryo-electron microscopy, or nuclear magnetic resonance (NMR) spectroscopy to determine the three-dimensional structure of C14orf108. These structural insights are crucial for the identification of potential binding sites that can be targeted by small molecules or other inhibitory agents. Alongside structural studies, functional assays might be employed to understand the activity of C14orf108, whether it acts as an enzyme, a signaling molecule, or plays a structural role within the cell. This multifaceted approach would provide a comprehensive picture of C14orf108's role in the cell, allowing for the targeted design of inhibitors that can modulate its function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates into DNA, inhibiting transcription. This could reduce the mRNA levels of AP5M1, thereby lowering its expression. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits eukaryotic protein synthesis by interfering with ribosomal translocation. It would decrease AP5M1 expression by blocking its translation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a kinase involved in the regulation of protein synthesis, potentially reducing the expression of proteins including AP5M1. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin inhibits RNA polymerase II, which is responsible for mRNA synthesis. Inhibition would decrease the transcription of genes such as AP5M1. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin inhibits bacterial RNA polymerase and would not directly affect eukaryotic AP5M1, but demonstrates how RNA polymerase inhibition could reduce protein expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine can raise endosomal pH and potentially affect the trafficking and expression of proteins mediated by adaptor complexes. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts transport between the endoplasmic reticulum and the Golgi apparatus, which might indirectly affect AP5M1 expression. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Puromycin causes premature chain termination during protein synthesis, which would non-selectively inhibit the expression of most proteins, including AP5M1. | ||||||
Emetine | 483-18-1 | sc-470668 sc-470668A sc-470668B sc-470668C | 1 mg 10 mg 50 mg 100 mg | $440.00 $900.00 $1400.00 $2502.00 | ||
Emetine inhibits protein synthesis by blocking elongation at the ribosomal level, which would reduce overall protein expression. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin interferes with protein synthesis by inhibiting peptidyl transferase activity on the ribosome, affecting protein expression. | ||||||